Stocks Research
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- MBX Biosciences, Inc. Biotechnology MBX$62.99 37 Health 37 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Trevi Therapeutics, Inc. Biotechnology TRVI$16.82 37 Health 37 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Strong Entry Strong EntryTiming looks favorable across trend, momentum, valuation, support, and catalysts.
- Syndax Pharmaceuticals, Inc. Biotechnology SNDX$19.94 37 Health 37 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Forte Biosciences, Inc. Biotechnology FBRX$76.99 37 Health 37 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- ORIC Pharmaceuticals, Inc. Biotechnology ORIC$12.62 37 Health 37 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Moderna, Inc. Biotechnology MRNA$140.33 36 Health 36 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Denali Therapeutics Inc. Biotechnology DNLI$22.08 36 Health 36 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Immunome, Inc. Biotechnology IMNM$26.81 36 Health 36 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Capricor Therapeutics, Inc. Biotechnology CAPR$9.06 36 Health 36 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- KalVista Pharmaceuticals Inc Biotechnology KALV$27.00 35 Health 35 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar covers and scores companies in the research universe.